ArticleBMC nutrition2026
Vitamin D status and cardiometabolic risk factors among hypertensive and normotensive adults: a hospital-based cross-sectional study in Nepal.
Article in BMC nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVitamin D deficiency is increasingly recognised as a risk factor for non-communicable diseases, including hypertension. However, evidence on their relationship remains inconsistent, particularly in middle and low-income countries like Nepal. This study aimed to assess the prevalence of vitamin D deficiency among hypertensive and normotensive adults, and identify the demographic, anthropometric and clinical risk factors among hypertensive adults attending a tertiary care hospital in Kathmandu, Nepal.
methodsA hospital-based cross-sectional study was conducted among 108 adults (54 hypertensive and 54 normotensive) at Nepal Medical College and Teaching Hospital from September 2024 to March 2025. Data on sociodemographic factors, anthropometric variables and clinical parameters were collected. Serum 25(OH)D was measured using Chemiluminescence Immunoassay (CLIA), and was categorised as sufficient (≥ 30 ng/ml), insufficient (20-29 ng/ml) and deficient (< 20 ng/ml). Blood pressure was classified according to the 7th Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Group comparisons were performed using the Chi-Square test, and significant variables were subjected to multiple logistic regression.
resultsOverall, 42.6% were vitamin D deficient. Although deficiency was more prevalent in hypertensive than normotensive, the association was only borderline significant (p = 0.05) and did not remain significant after post-hoc correction. In multiple logistic regression, abdominal obesity (AOR: 2.8; 95% CI: 1.2-6.7; p = 0.019), dyslipidemia (AOR: 2.8; 95% CI: 1.2-7.2; p = 0.024) and having a family history of hypertension (AOR: 2.7; 95% CI: 1.1-6.8; p = 0.028) were independently associated with increased odds of hypertension. The overall model explained 24% of variance in hypertensive status (Nagelkerke R
conclusionsDyslipidemia, abdominal obesity and family history were significant predictors of hypertension in this cohort, while vitamin D deficiency showed a non-significant association with hypertension. Nonetheless, the high prevalence of vitamin D deficiency highlights the need for increased public health awareness and preventive healthcare strategies. Larger population-based studies are needed to understand the role of vitamin D in the prevention and control of hypertension in Nepal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.